Discover
GMED
Globus Medical, Inc.
85.84
3 x 85.81
1 x 85.92
bid
ask
-
0.31
0.35%
02:54 PM
timesize
| Ytd | -1.68% | |
| 1y | 44.45% |
84.70
day range
86.83
54.15
52 week range
101.40
| Open | 85.90 | Prev Close | 86.15 | Low | 84.70 | High | 86.83 | Mkt Cap | 11.57B |
| Vol | 1.05M | Avg Vol | 1.82M | EPS | 4.44 | P/E | 19.33 | Forward P/E | 15.43 |
| Beta | 0.95 | Short Ratio | 3.48 | Inst. Own | 87.96% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 79.51 | 200-d Avg | 84.62 | 1yr Est | 103.23 |
| Income Statement | |||
| Total Revenue | 789.61M | ||
| Revenues (USD) | 789.61M | ||
| Cost of Revenue | 241.44M | ||
| Gross Profit | 548.17M | ||
| Operating Expenses | 365.74M | ||
| Research and Development Expense | 36.32M | ||
| Selling, General and Administrative Expense | 286.82M | ||
| Operating Income | 182.43M | ||
| Interest Expense | -7.07M | ||
| Income Tax Expense | 38.25M | ||
| Net Income | 151.57M | ||
| Net Income Common Stock | 151.57M | ||
| Net Income Common Stock (USD) | 151.57M | ||
| Consolidated Income | 151.57M | ||
| Earnings per Basic Share | 1.12 | ||
| Earnings per Basic Share (USD) | 1.12 | ||
| Earnings per Diluted Share | 1.10 | ||
| Earning Before Interest & Taxes (EBIT) | 182.74M | ||
| Earning Before Interest & Taxes (USD) | 182.74M | ||
| Weighted Average Shares | 135.05M | ||
| Weighted Average Shares Diluted | 137.38M | ||
| Balance Sheet | |||
| Cash and Equivalents | 507.75M | ||
| Cash and Equivalents (USD) | 507.75M | ||
| Investments | 332.76M | ||
| Investments Current | 87.40M | ||
| Investments Non-Current | 245.36M | ||
| Trade and Non-Trade Receivables | 692.18M | ||
| Current Assets | 2.22B | ||
| Property, Plant & Equipment Net | 592.68M | ||
| Total Assets | 5.49B | ||
| Debt Current | 14.39M | ||
| Total Debt | 111.19M | ||
| Current Liabilities | 479.35M | ||
| Debt Non-Current | 96.81M | ||
| Total Liabilities | 719.66M | ||
| Accumulated Retained Earnings (Deficit) | 1.53B | ||
| Accumulated Other Comprehensive Income | 11.20M | ||
| Shareholders Equity | 4.77B | ||
| Shareholders Equity (USD) | 4.77B | ||
| Assets Non-Current | 3.27B | ||
| Total Debt (USD) | 111.19M | ||
| Deferred Revenue | 27.98M | ||
| Goodwill and Intangible Assets | 2.13B | ||
| Inventory | 810.90M | ||
| Liabilities Non-Current | 240.31M | ||
| Trade and Non-Trade Payables | 106.94M | ||
| Tax Assets | 271.73M | ||
| Tax Liabilities | 48.38M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 69.50M | ||
| Net Cash Flow from Financing | -134.50M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -53.20M | ||
| Capital Expenditure | -33.17M | ||
| Net Cash Flow - Business Acquisitions and Disposals | -1.50M | ||
| Issuance (Purchase) of Equity Shares | -125.09M | ||
| Net Cash Flow from Investing | -129.05M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -94.38M | ||
| Net Cash Flow from Operations | 209.74M | ||
| Effect of Exchange Rate Changes on Cash | 598.00K | ||
| Share Based Compensation | 13.38M | ||